This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
Retraction: Cyclic AMP-response element regulated cell cycle arrests in cancer cells
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAdenosine and Purinergic Signaling · Cancer Research and Treatments · Autophagy in Disease and Therapy
Following the publication of this article, concerns were raised with results presented in Figs 2–7. Specifically,
In response to these concerns, author JC stated that they did not consent to being included as an author and requested retraction of the article,
In light of the above unresolved concerns that question the reliability and integrity of these results, the PLOS One editors retract this article.
JC agreed with the retraction. PW, SH, FW, YR, MH, and XW either did not respond directly or could not be reached.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Wang P, Huang S, Wang F, Ren Y, Hehir M, Wang X, et al. Cyclic AMP-response element regulated cell cycle arrests in cancer cells. P Lo S One. 2013;8(6):e 65661. doi: 10.1371/journal.pone.0065661 23840351 PMC 3696002 · doi ↗ · pubmed ↗
- 2Patel R, Gao M, Ahmad I, Fleming J, Singh LB, Rai TS, et al. Sprouty 2, PTEN, and PP 2A interact to regulate prostate cancer progression. J Clin Invest. 2013;123(3):1157–75. doi: 10.1172/JCI 63672 23434594 PMC 3582117 · doi ↗ · pubmed ↗